BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 429874)

  • 1. Regulation of fibrinogen biosynthesis: effect of fibrin degradation products, low-molecular-weight peptides of fibrinogenolysis, and fibrinopeptides A and B.
    Kessler CM; Bell WR
    J Lab Clin Med; 1979 May; 93(5):758-67. PubMed ID: 429874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of homologous thrombin and fibrinogen degradation products on fibrinogen synthesis in rabbits.
    Kessler CM; Bell WR
    J Lab Clin Med; 1979 May; 93(5):768-82. PubMed ID: 219123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots.
    Weisel JW; Veklich Y; Gorkun O
    J Mol Biol; 1993 Jul; 232(1):285-97. PubMed ID: 8331664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of products of degradation of fibrinogen A and B on the arterial blood pressure in the rat.
    Barczak-Osińska J; Buczko W; Wiśniewski K
    Pol J Pharmacol Pharm; 1983; 35(4):279-83. PubMed ID: 6664935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Action of proteolytic enzymes on fibrinogen].
    Jamet M; Levy G
    Ann Anesthesiol Fr; 1978; 19(8):687-91. PubMed ID: 31111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen synthesis in rabbits: effects of altered levels of circulating fibrinogen.
    Alving BM; Bell WR; Evatt BL
    Am J Physiol; 1977 May; 232(5):H478-84. PubMed ID: 860765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin monomer and fibrinopeptide B act additively to increase DNA synthesis in smooth muscle cells cultured from human saphenous vein.
    Sturge J; Carey N; Davies AH; Powell JT
    J Vasc Surg; 2001 Apr; 33(4):847-53. PubMed ID: 11296341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
    Dempfle CE; Argiriou S; Alesci S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
    Ann N Y Acad Sci; 2001; 936():210-4. PubMed ID: 11460476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence of release of fibrinopeptide A from fibrinogen molecules by thrombin or Atroxin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    J Lab Clin Med; 1995 Mar; 125(3):384-91. PubMed ID: 7897305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fibrin degradation products and thrombin on fibrinogen synthesis.
    Ittyerah TR; Weidner N; Wochner RD; Sherman LA
    Br J Haematol; 1979 Dec; 43(4):661-8. PubMed ID: 526446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of bovine fibrinopeptides on the central action of chlorpromazine and amphetamine in rats.
    Buczko W
    Acta Neurobiol Exp (Wars); 1976; 36(4):447-54. PubMed ID: 983820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of fibrin formation and proteolysis during intravenous administration of ancrod.
    Dempfle CE; Argiriou S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
    Blood; 2000 Oct; 96(8):2793-802. PubMed ID: 11023513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Nakahata T; Saitoh H
    Rinsho Byori; 1992 Jul; 40(7):789-94. PubMed ID: 1507499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urokinase has direct catalytic activity against fibrinogen and renders it less clottable by thrombin.
    Weitz JI; Leslie B
    J Clin Invest; 1990 Jul; 86(1):203-12. PubMed ID: 2365816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of D and E domains in the migration of vascular smooth muscle cells into fibrin gels.
    Kodama M; Naito M; Nomura H; Iguchi A; Thompson WD; Stirk CM; Smith EB
    Life Sci; 2002 Jul; 71(10):1139-48. PubMed ID: 12095535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.